Skip to Content
Merck
CN

Key Documents

View All Documentation

366625

5-Fluoro-2-methylbenzoic acid

99%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
FC6H3(CH3)CO2H
CAS Number:
33184-16-6
Molecular Weight:
154.14
UNSPSC Code:
12352100
PubChem Substance ID:
24862679
MDL number:
MFCD00042294
Assay:
99%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

assay

99%

mp

130-132 °C (lit.)

functional group

carboxylic acid, fluoro

SMILES string

Cc1ccc(F)cc1C(O)=O

InChI

1S/C8H7FO2/c1-5-2-3-6(9)4-7(5)8(10)11/h2-4H,1H3,(H,10,11)

InChI key

JVBLXLBINTYFPR-UHFFFAOYSA-N

Application

5-Fluoro-2-methylbenzoic acid may be used in the preparation of:
  • 5-fluoro-3-hydroxy-2-methylbenzoic acid
  • 5-fluoro-2-methyl-3-nitrobenzoic acid methyl ester
  • 5-fluoro-N,2-dimethylbenzamide

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKBC2088V
MKBC2088
03301TD
U17502
13803TA

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Multkilogram Scale-Up of a Reductive Alkylation Route to a Novel PARP Inhibitor.
Gillmore AT, et al.
Organic Process Research & Development, 16(12), 2063-2072 (1999)
E Takashiro et al.
Bioorganic & medicinal chemistry, 7(9), 2063-2072 (1999-10-26)
The structure-activity relationship of HIV-1 protease (HIV-1 PR) inhibitors containing alpha-hydroxy-beta-amino acids is discussed. We demonstrated that substituent groups on the P1 aromatic rings of the inhibitors exert significant influence on their biological activity. Inhibitors bearing an alkyl or a
Xing Fan et al.
Bioorganic & medicinal chemistry, 19(16), 4935-4952 (2011-07-23)
HIV-1 integrase (IN) is a validated therapeutic target for antiviral drug design. However, the emergence of viral strains resistant to clinically studied IN inhibitors demands the discovery of novel inhibitors that are structurally as well mechanistically different. Herein, we describe

Global Trade Item Number

SKUGTIN
366625-1G04061825584829